Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study
培米替尼治疗既往接受过治疗的携带FGFR2融合或重排的局部晚期或转移性胆管癌中国患者:一项II期研究
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5273
Shi, Guo-Ming; Huang, Xiao-Yong; Wen, Tian-Fu; Song, Tian-Qiang; Kuang, Ming; Mou, Hai-Bo; Bao, Le-Qun; Zhao, Hai-Tao; Zhao, Hong; Feng, Xie-Lin; Zhang, Bi-Xiang; Peng, Tao; Zhang, Yu-Bao; Li, Xiang-Cheng; Yu, Hong-Sheng; Cao, Yu; Liu, Lian-Xin; Zhang, Ti; Wang, Wei-Lin; Ran, Jiang-Hua; Liu, Ying-Bin; Gong, Wei; Chen, Ming-Xia; Cao, Lian; Luo, Yang; Wang, Yan; Zhou, Hui; Yang, Guo-Huan; Fan, Jia; Zhou, Jian